Enanta Pharmaceuticals Inc (ENTA)

[willyw]

I was excited to see this too. To already own a good HBV asset is an advantage, but being able to select various in development compounds that might play well with that asset (EDP-514) and/or with a nuke, things could ramp up quickly. It brings to mind the Abbott/Abbvie collaboration where not once but twice the two companies were able to tailor complimentary compounds in the HCV space.

I'd venture that they already have a start or starts (various potential compounds) and hope we may soon get an update on when and whether to expect preclinical data or sense on how far away a trial could be.
I'll admit- I have almost stopped following the HBV space since the 514 asset seemed to have been shelved.

It also came to my mind that Jay Luly often refers to Enanta as a drug discovery company.
I'm wondering, if that were the case, (as it pertains to a certain PFE lawsuit) wouldn't it behoove you to have a solid branch of the company to protect those IP assets?

It would be windfall for investors if there was a settlement or win against Pfizer over Covid intellectual property this year.